Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP

Launched by ASTEN SANTE · Jul 21, 2023

Keywords

ClinConnect Summary

The IPIAM study is exploring how involving patients in their own care through remote monitoring can improve the use of CPAP machines for treating obstructive sleep apnea (OSA). This is particularly important for patients who have cardiovascular risks and may struggle to consistently use their CPAP devices. The study aims to see if monitoring patient data daily can help identify issues early on, making it easier for both patients and healthcare providers to address any problems with using the CPAP device effectively.

To participate in this study, you need to be an adult recently diagnosed with OSA and have at least one cardiovascular risk factor, such as obesity or diabetes. You should also have a smartphone and be willing to use connected devices throughout the study. If you join, you can expect to receive remote support and monitoring to help you adhere to your treatment, which may also include checking for heart rhythm issues using a smartwatch. This study is currently recruiting participants, and your involvement could play a crucial role in improving how we manage OSA treatment for people at risk.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult with newly diagnosed OSA (with central apnea index \<5 ev/h), justifying CPAP and with low sleepiness (Epworth score \<11 at inclusion).
• • Patient with at least 1 cardiovascular risk factor (obesity, type I or II diabetes with or without treatment, permanent hypertension with or without treatment, heart failure with preserved ejection fraction, valve disease, history of atrial fibrillation, history of ischaemic heart disease, history of stroke).
• • Patient with a smartphone and who agrees to use connected objects during the study.
• • Signed informed consent form,
• • Subject affiliated to a health insurance system, or is a beneficiary.
• Exclusion Criteria:
• • Patients already fitted with a CPAP machine,
• • Patients with permanent atrial fibrillation,
• • Patients whose state of health is not stable or requires heavy treatment,
• • Patients with cognitive problems.
• • Patients participating in another intervention research in pulmonology.
• • Vulnerable subject